Series D Funded Health Care Startups
Disclosed Series D rounds in this list run from $1M (Brisk Health, 2023-12-26) up to $500M (Commure, 2021-09-16).
Disclosed Series D rounds in this list run from $1M (Brisk Health, 2023-12-26) up to $500M (Commure, 2021-09-16). The $500M round dwarfs the next-largest disclosed amount visible here ($304M: Medable on 2021-10-26), and most other rounds sit well below the top tier (for example, $260M Imperative Care on 2021-07-15; $225M Forward on 2021-03-11; $200M Synchron on 2025-11-08 and DispatchHealth on 2021-03-03).
The geography is concentrated at the city level: San Francisco appears repeatedly (Elation Health 2022-07-26 $50M; Reify Health 2022-04-21 $220M; Commure 2021-09-16 $500M; DispatchHealth is Denver, but Modern Health is also listed as San Francisco 2021-02-11 $74M; plus Star Therapeutics is in South San Francisco 2025-09-29 $125M). Temporally, the shown rounds span 2021-02-11 (Modern Health) through 2025-11-08 (Synchron), with multiple sub-quarters of activity clustered in late 2021 and early 2022 and a second wave in 2024–2025.
Most recent rounds
39 shownRelated listings
Frequently asked
What’s the largest disclosed Series D round in this list, and how extreme is it versus the rest?
Commure’s $500M (2021-09-16) is the top disclosed amount. It substantially exceeds the next-largest disclosed amount shown, Medable’s $304M (2021-10-26), while the low end includes Brisk Health at just $1M (2023-12-26).
Is there a tight concentration by time among the most recent rounds shown?
Yes. Several high-dollar rounds appear clustered in the mid-to-late 2024 and 2025 window, including Star Therapeutics $125M (2025-09-29), Thyme Care $97M (2025-09-23), Strive Health $300M (2025-09-14), and Synchron $200M (2025-11-08).
Do any cities show over-representation compared with other geographies here?
San Francisco and the immediate Bay Area stand out. San Francisco is listed for Elation Health ($50M on 2022-07-26), Reify Health ($220M on 2022-04-21), Commure ($500M on 2021-09-16), and Modern Health ($74M on 2021-02-11), while Star Therapeutics is based in South San Francisco ($125M on 2025-09-29).
Where does the low end of disclosed funding land, relative to the typical range in this sample?
The floor disclosed amount is $1M for Brisk Health (2023-12-26). Even the next-lowest visible disclosures remain far higher (for example, Phraxis at $5M on 2022-03-24 and JET HEALTH at $5M on 2021-04-16), indicating a pronounced right-skew toward larger rounds.
Are there any clear outliers worth prioritizing for diligence because of scale?
Besides the overall top at $500M (Commure, 2021-09-16), the list includes multiple large “upper-tier” rounds that are meaningfully above the common mid-range: Medable $304M (2021-10-26), Strive Health $300M (2025-09-14), Imperative Care $260M (2021-07-15), and Forward $225M (2021-03-11).
What does the date span suggest about the cycle of disclosed rounds in this set?
The visible rounds start on 2021-02-11 with Modern Health ($74M) and end on 2025-11-08 with Synchron ($200M). The distribution shows activity across multiple years, with dense entries in 2021–2022 (for example, Commure, Medable, Imperative Care, Forward, and DispatchHealth in 2021–2022) and a renewed set of high rounds in 2024–2025 (including HistoSonics $102M on 2024-08-15 and Transcarent $126M on 2024-05-02).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.